Nontuberculous mycobacteria (NTM)

June 1, 2020June 1, 2020

Most Bronchiectasis Patients in Europe Not Tested for NTM Infection as Recommended, Survey Suggests

News

Many bronchiectasis patients in Europe are not being tested for nontuberculous mycobacteria (NTM) infection before starting macrolide antibiotic treatment, as recommended by current guidelines, according to a small survey of physicians ... Read more

August 15, 2017

Nitric Oxide Delivered to First Patient Enrolled in Phase 2 Trial for Serious Respiratory Infection

News

The first patient enrolled in a Phase 2 trial for patients with a serious infection — Mycobacterium abscessus complex (MABSC) — has successfully received the first dose of nitric oxide ... Read more

February 2, 2016February 2, 2016

FDA Gives Nod to Start of Phase 1 Drug Trial for NTM Infections

News

Matinas BioPharma Holdings of Bedminster, N.J., recently announced that its investigational new drug (IND) application to the U.S. Food and Drug Administration is open and the company has been authorized to ... Read more